Literature DB >> 16020493

Routine isotope-dilution liquid chromatography-tandem mass spectrometry assay for simultaneous measurement of the 25-hydroxy metabolites of vitamins D2 and D3.

Zoë Maunsell1, Dennis J Wright, Sandra J Rainbow.   

Abstract

BACKGROUND: Measurement of 25-hydroxyvitamin D2 and D3 (25-OH D2 and D3) is essential for investigating vitamin D deficiency. Competitive binding techniques are unable to distinguish between the 2 metabolites and suffer from interference from other hydroxy metabolites of vitamin D.
METHODS: We used isotope-dilution liquid chromatography-tandem mass spectrometry (ID-LC-MS/MS) for routine determination of 25-OH D2 and D3 with a stable-isotope-labeled internal standard (IS). Serum samples (100 microL) were denatured with methanol-propanol containing IS, vortex-mixed, extracted into hexane, and dried under nitrogen. The reconstituted extract was chromatographed on a BDS C8 HPLC column, and the metabolites and IS were detected by electrospray ionization MS/MS in multiple-reaction monitoring mode.
RESULTS: 25-OH D2 and D3 and the IS nearly coeluted, whereas 1alpha-hydroxyvitamin D3 was separated; total run time was 8 min. The interassay CVs for 25-OH D2 were 9.5% and 8.4% at 52 and 76 nmol/L, respectively, and for 25-OH D3 were 5.1% and 5.6% at 55 and 87 nmol/L, respectively. The detection limit of the present method was <4 nmol/L for both metabolites. Method comparison with a commercial RIA measuring total 25-hydroxyvitamin D showed good correlation: y=0.97x - 2.7 nmol/L (r=0.91). The analytical system can assay 100 samples in 12.5 h.
CONCLUSIONS: This simple robust interference-free LC-MS/MS assay is suitable for routine measurement of the 25-hydroxy metabolites of vitamins D2 and D3 in human serum. The assay has been in use for 9 months and has been used to assay more than 6000 routine samples.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16020493     DOI: 10.1373/clinchem.2005.052936

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  89 in total

1.  Bone mineral density in Klinefelter syndrome is reduced and primarily determined by muscle strength and resorptive markers, but not directly by testosterone.

Authors:  A Bojesen; N Birkebæk; K Kristensen; L Heickendorff; L Mosekilde; J S Christiansen; C H Gravholt
Journal:  Osteoporos Int       Date:  2010-07-24       Impact factor: 4.507

2.  Differential effects of calcium- and vitamin D-fortified milk with FOS-inulin compared to regular milk, on bone biomarkers in Chinese pre- and postmenopausal women.

Authors:  Marlena C Kruger; Yoke Mun Chan; Barbara Kuhn-Sherlock; Lee Ting Lau; ChinChin Lau; Y S Chin; Joanne M Todd; Linda M Schollum
Journal:  Eur J Nutr       Date:  2015-08-12       Impact factor: 5.614

3.  The assessment of circulating 25(OH)D and 1,25(OH)2D: where we are and where we are going.

Authors:  Bruce W Hollis; Ronald L Horst
Journal:  J Steroid Biochem Mol Biol       Date:  2007-01-02       Impact factor: 4.292

4.  Principles and applications of liquid chromatography-mass spectrometry in clinical biochemistry.

Authors:  James J Pitt
Journal:  Clin Biochem Rev       Date:  2009-02

5.  Metabolic profiling of major vitamin D metabolites using Diels-Alder derivatization and ultra-performance liquid chromatography-tandem mass spectrometry.

Authors:  Pavel A Aronov; Laura M Hall; Katja Dettmer; Charles B Stephensen; Bruce D Hammock
Journal:  Anal Bioanal Chem       Date:  2008-04-24       Impact factor: 4.142

6.  Vitamin D status indicators in indigenous populations in East Africa.

Authors:  Martine F Luxwolda; Remko S Kuipers; Ido P Kema; E van der Veer; D A Janneke Dijck-Brouwer; Frits A J Muskiet
Journal:  Eur J Nutr       Date:  2012-08-10       Impact factor: 5.614

7.  Cord blood vitamin D status impacts innate immune responses.

Authors:  Valencia P Walker; Xiaoran Zhang; Ida Rastegar; Philip T Liu; Bruce W Hollis; John S Adams; Robert L Modlin
Journal:  J Clin Endocrinol Metab       Date:  2011-04-06       Impact factor: 5.958

8.  Vitamin D insufficiency common in newborns, children and pregnant women living in Newfoundland and Labrador, Canada.

Authors:  Leigh A Newhook; Scott Sloka; Marie Grant; Edward Randell; Christopher S Kovacs; Laurie K Twells
Journal:  Matern Child Nutr       Date:  2009-04       Impact factor: 3.092

Review 9.  Vitamin D and metabolites measurement by tandem mass spectrometry.

Authors:  Johannes M W van den Ouweland; Michael Vogeser; Silvia Bächer
Journal:  Rev Endocr Metab Disord       Date:  2013-06       Impact factor: 6.514

10.  Simvastatin does not affect vitamin d status, but low vitamin d levels are associated with dyslipidemia: results from a randomised, controlled trial.

Authors:  Lars Rejnmark; Peter Vestergaard; Lene Heickendorff; Leif Mosekilde
Journal:  Int J Endocrinol       Date:  2009-07-21       Impact factor: 3.257

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.